He said: It is well established that better mental health tends to follow from better physical health and since the 1880s we have known that diabetes is associated with depression, although I think its unlikely that using GLP-1R agonists alone as treatments for depression or anxiety will work. Prof Eduard Vieta, a professor of psychiatry at the University of Barcelona and editor in chief of the European College of Neuropsychopharmacology journal, said: From a clinical perspective, these findings are reassuring regarding the psychiatric safety of GLP-1 receptor agonists and suggest a potential role not only in preventing worsening but also, possibly, in improving mental health outcomes
This approach has no comparative trial data but is mechanistically defensible given GHK-Cu's dose-dependent effects on fibroblast activity observed in vitro
It works for a lot of dogs
Challenges and opportunities: using omics to generate testable insights into pathogenic mechanisms in preclinical seropositive rheumatoid arthritis
It's a big problem, a very big problem, and the ultra-processed foods
July 27, 2026: FDA peptide panel narrowly votes to add unapproved drugs to compounding list Major Stories The FDAs peptide panel voted to add six unapproved compounds to the 503A bulks compounding list, despite agency scientists' warnings about the consequences
